Kilobase-scale nickase-targeting (KNIT) editing enables single-nick-based DNA insertion across genomic loci and cell types, supporting insertion of DNA fragments exceeding 10 kb, with high efficiency and minimal unwanted off-target effects.
CRISPR-Cas9 has transformed gene editing; however, it is based on doublestrand
DNA breaks, which may result in unintentional mutations and structural alterations,
thereby limiting its clinical translation. Instead of DSBs, new precision instruments,
including prime editing, can be used to perform accurate search-and-replace DNA editing
with a Cas9 nickase and reverse transcriptase. Prime editing can perform all base substitutions
and small edits with improved precision and reduced off-target activity, which has
promising results in disease modelling with patient-derived organoids. Nonetheless, it is
cumbersome, inefficient, and thus hard to deliver. This is improved by the Programmable
Addition via Site-specific Targeting Elements system, which uses Prime editing in combination
with serine integrases to insert large DNA sequences with no gaps to provide
lasting gene replacement and maintain natural gene regulation. Emerging delivery options,
including lipid nanoparticles, dual adeno-associated virus systems, and virus-like
particles, allow the delivery to be transient and tissue-targeted, which minimizes the risks
over the long-term. Early clinical translation efforts are currently underway, with the first
FDA-approved trial of one Prime editing-based therapy, but it has been struggling with
efficiency, safety, and delivery. Future success will depend on predictive machinelearning
devices and strictly controlled editing systems. Genome engineering is evolving
from a DNA-cutting system to a precise and programmable genome editing system,
which may support the future development of safer and more precise therapeutic strategies.
Vikash Kumar, Aman Kumar, Balak Das Kurmi· Current Pharmacogenomics and...· 0 citations
An RNA-guided bridge recombinase system is engineered through rational mutagenesis and AI-assisted directed evolution, enabling programmable chromosomal rearrangements in both plant and mammalian cells and achieving up to a 29.8-fold increase in activity.
Rui Gao, Jingjing Wei, Chao Sun et al.· Trends in Biotechnology· 0 citations
This study demonstrates donor-complementary prime editing (DoPE) as a one-step, DSB-free and library-compatible method for precise insertion of large DNA fragments without requiring recombinases or transposases.
Yun-Zheng Fang, Jingyao Tang, Jia-Wei Xi et al.· Nature Biotechnology· 0 citations
Compared with multiplex Cas9 editing, BEKI markedly reduced chromosomal translocations while preserving cell viability, and provides a streamlined and scalable strategy for multiplex CAR T-cell engineering with improved genomic stability, advancing safer next-generation cell therapies for cancer and autoimmune diseases.
Glaser Viktor, Becker Lily Jo, Fuster-García Carla et al.· Molecular Therapy· 0 citations
This review compares Cas9-mediated homology-directed repair (HDR) with generations of cytosine base editors (CBE1–CBE3), adenine base editors (ABE1-ABE7), and prime editors (PE1–PE3b), focusing on their mechanistic distinctions, efficiencies, delivery challenges, and therapeutic applications.
Anoushka Sinha· American Journal of Student...· 0 citations
A programmable gene replacement tool, named prime assembly (PA), which adapts prime editors to produce one or two pairs of 3'-flaps on both the genome and donor DNA, allowing megabase-scale genomic excision and/or kilobase-scale donor insertion at the gene of interest.
Hojun Jung, Bada Jeong, Yong-Woo Kim et al.· Nature Biotechnology· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.